These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8910624)

  • 21. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
    Hennequin C; Giocanti N; Favaudon V
    Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
    Choy H; Yee L; Cole BF
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxic and genotoxic effects of paclitaxel (Taxol) and radiation in a squamous cell carcinoma cell line of the larynx.
    Preisler VK; Stopper H; Schindler D; Friedl R; Pfreundner L; Hoppe F; Hagen R
    Acta Otolaryngol; 1998 Jul; 118(4):600-5. PubMed ID: 9726690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined effect of procarbazine and ionizing radiation on mouse jejunal crypts.
    Connor AM; Sigdestad CP
    Chemotherapy; 1978; 24(6):368-73. PubMed ID: 699678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irradiation and Taxol treatment result in non-monotonous, dose-dependent changes in the motility of glioblastoma cells.
    Hegedus B; Zách J; Czirók A; Lövey J; Vicsek T
    J Neurooncol; 2004; 67(1-2):147-57. PubMed ID: 15072462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental study of taxol combining accelerated radiation on laryngeal carcinoma cells].
    Liu J; Wang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Sep; 16(9):481-3. PubMed ID: 15515539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose irradiation and short-exposure suboptimal-dose paclitaxel adversely modulate metastatic potential of squamous carcinoma cells.
    Lövey J; Fazekas K; Ladányi A; Németh G; Tímár J
    Strahlenther Onkol; 2003 Dec; 179(12):812-8. PubMed ID: 14652669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of Taxol combined with radiations in human squamous cell carcinoma spheroids.
    Griffon-Etienne G; Merlin JL; Marchal C
    Cancer Lett; 1996 Dec; 109(1-2):23-32. PubMed ID: 9020899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taxol as a radiation sensitizer: a flow cytometric study.
    Steren A; Sevin BU; Perras J; Ramos R; Angioli R; Nguyen H; Koechli O; Averette HE
    Gynecol Oncol; 1993 Jul; 50(1):89-93. PubMed ID: 8102348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
    Kirichenko AV; Rich TA; Newman RA; Travis EL
    Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiosensitization of paclitaxel combined with radiation on nasopharygneal carcinoma cells (CNE-I) in vitro].
    Yuan ZY; Yang WZ; Jin J; Gao L; Liu XF; Xu GZ
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):649-52. PubMed ID: 18246791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of taxol as a potential radiation sensitizer.
    Choy H; Rodriguez FF; Koester S; Hilsenbeck S; Von Hoff DD
    Cancer; 1993 Jun; 71(11):3774-8. PubMed ID: 8098270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paclitaxel and simultaneous radiation in locally advanced stage IIIA/B non-small cell lung cancer: a clinical phase I study.
    Vogt HG; Kolotas C; Martin T; Schneider LV; Goes-Schmieder R; Mitrou PS; Diergarten K; Kober B; Zamboglou N
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):120-3. PubMed ID: 9007138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ICRF-159 enhancement of radiation response in combined modality therapies. II. Differential responses of tumour and normal tissues.
    Kovacs CJ; Evans MJ; Burholt DR; Schenken LL
    Br J Cancer; 1979 May; 39(5):524-30. PubMed ID: 486308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Docetaxel enhances tumor radioresponse in vivo.
    Mason KA; Hunter NR; Milas M; Abbruzzese JL; Milas L
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2431-8. PubMed ID: 9815644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Taxol in combination with acute and low dose rate irradiation.
    Minarik L; Hall EJ
    Radiother Oncol; 1994 Aug; 32(2):124-8. PubMed ID: 7972905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between micronuclei induction and cell survival in V79 cells exposed to paclitaxel (taxol) in conjunction with radiation.
    Jagetia GC; Adiga SK
    Mutat Res; 1997 Jun; 377(1):105-13. PubMed ID: 9219585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Taxol: a novel radiation sensitizer.
    Tishler RB; Schiff PB; Geard CR; Hall EJ
    Int J Radiat Oncol Biol Phys; 1992; 22(3):613-7. PubMed ID: 1346533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection by WR-2721 against radiation plus cis-diamminedichloroplatinum II caused injury to colonic epithelium in mice.
    Ito H; Komaki R; Milas L
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):899-903. PubMed ID: 8138443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of proliferative status and clonogen content on the response of mouse jejunal crypts to split-dose irradiation.
    Thames HD; Ruifrok AC; Mason KA
    Radiat Res; 1997 Feb; 147(2):172-8. PubMed ID: 9008209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.